Schwab US Large Cap Growth ETF vs Twist Bioscience Corp — how do they compare? Schwab US Large Cap Growth ETF trades at $34.25, while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). Which is the better fit depends on your goals.
| SCHG | TWST | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $35.30 | $102.88 |
52-Week Low | $28.10 | $24.16 |
Market Cap | — | $5.45B |
Enterprise Value | — | $5.37B |
Trailing returns across standard periods
Latest headlines on both assets
SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.
Read more on SCHG →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →